ijms-logo

Journal Browser

Journal Browser

Filaggrin

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 12256

Special Issue Editor


E-Mail Website
Guest Editor
Toulouse Institute for Infectious and Inflammatory Diseases, Infinity, Toulouse University, CNRS, Inserm, UPS, Toulouse, France
Interests: biochemistry and cell biology; cutaneous biology; keratinocyte differentiation; stratum corneum properties and functions; skin inflammatory diseases

Special Issue Information

Dear Colleagues,

Firstly identified in the late sixties as the “basic histidine-rich protein” and subsequently renamed in 1981, filaggrin (for filament aggregating protein) is now known as a key protein for epidermal barrier functions, and as a biomarker of normal keratinocyte differentiation. During cornification, filaggrin interacts with and promotes aggregation of keratin filaments; then it is degraded into amino-acids that are necessary for the hydration, acidic pH and photo-protective properties of the upper epidermis; a subset of filaggrin molecules is cross-linked to the cornified cell envelope; and filaggrin may display anti-microbial properties. Absence of filaggrin in either reconstructed 3D skin models or knockout mice is detrimental for a correct epidermal architecture and an efficient skin permeability barrier. The complex metabolism of filaggrin involved several post-translational modifications and various enzymes, including proteases and arginine deiminases. Filaggrin and its paralogs of the S100-fused type protein family share a marked bias in amino-acid composition, similar molecular structure with intrinsically disordered regions, and localization of a large precursor into liquid-like membrane-less condensates in the cytoplasm of differentiated keratinocytes. This suggests that liquid-liquid phase separation is a driving force for epidermal barrier formation.

Our interest about filaggrin has grown increasingly when it has been demonstrated that loss-of-function mutations of the filaggrin gene are a strong risk factor for atopic dermatitis and responsible for ichthyosis vulgaris. This profoundly changed the understanding of atopic diseases. Several studies suggest a link between filaggrin gene mutational profile and gastric tumors, as well as prediction of therapy response in carcinomas.

As a whole, filaggrin interests dermatologists, allergists, oncologists and basic researchers of public laboratories and private (pharmaceutical and cosmetic) companies.

This Special Issue aims to publish review articles and original studies, both at the basic and translational levels, to provide a broad up-to-date overview of the importance of filaggrin in pathophysiological processes.

Dr. Michel Simon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • filaggrin
  • keratinocytes
  • epidermal barrier 
  • atopic diseases 
  • post-translational modifications 
  • SFTP family 
  • late differentiation 
  • biomarker 
  • ichthyosis
  • cancer

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 1977 KiB  
Article
Carboxamide Derivatives Are Potential Therapeutic AHR Ligands for Restoring IL-4 Mediated Repression of Epidermal Differentiation Proteins
by Gijs Rikken, Noa J. M. van den Brink, Ivonne M. J. J. van Vlijmen-Willems, Piet E. J. van Erp, Lars Pettersson, Jos P. H. Smits and Ellen H. van den Bogaard
Int. J. Mol. Sci. 2022, 23(3), 1773; https://doi.org/10.3390/ijms23031773 - 4 Feb 2022
Cited by 7 | Viewed by 2165
Abstract
Atopic dermatitis (AD) is a common T-helper 2 (Th2) lymphocyte-mediated chronic inflammatory skin disease characterized by disturbed epidermal differentiation (e.g., filaggrin (FLG) expression) and diminished skin barrier function. Therapeutics targeting the aryl hydrocarbon receptor (AHR), such as coal tar and tapinarof, [...] Read more.
Atopic dermatitis (AD) is a common T-helper 2 (Th2) lymphocyte-mediated chronic inflammatory skin disease characterized by disturbed epidermal differentiation (e.g., filaggrin (FLG) expression) and diminished skin barrier function. Therapeutics targeting the aryl hydrocarbon receptor (AHR), such as coal tar and tapinarof, are effective in AD, yet new receptor ligands with improved potency or bioavailability are in demand to expand the AHR-targeting therapeutic arsenal. We found that carboxamide derivatives from laquinimod, tasquinimod, and roquinimex can activate AHR signaling at low nanomolar concentrations. Tasquinimod derivative (IMA-06504) and its prodrug (IMA-07101) provided full agonist activity and were most effective to induce FLG and other epidermal differentiation proteins, and counteracted IL-4 mediated repression of terminal differentiation. Partial agonist activity by other derivatives was less efficacious. The previously reported beneficial safety profile of these novel small molecules, and the herein reported therapeutic potential of specific carboxamide derivatives, provides a solid rationale for further preclinical assertation. Full article
(This article belongs to the Special Issue Filaggrin)
Show Figures

Figure 1

Review

Jump to: Research

29 pages, 1174 KiB  
Review
Revisiting the Roles of Filaggrin in Atopic Dermatitis
by Verena Moosbrugger-Martinz, Corinne Leprince, Marie-Claire Méchin, Michel Simon, Stefan Blunder, Robert Gruber and Sandrine Dubrac
Int. J. Mol. Sci. 2022, 23(10), 5318; https://doi.org/10.3390/ijms23105318 - 10 May 2022
Cited by 45 | Viewed by 9380
Abstract
The discovery in 2006 that loss-of-function mutations in the filaggrin gene (FLG) cause ichthyosis vulgaris and can predispose to atopic dermatitis (AD) galvanized the dermatology research community and shed new light on a skin protein that was first identified in 1981. [...] Read more.
The discovery in 2006 that loss-of-function mutations in the filaggrin gene (FLG) cause ichthyosis vulgaris and can predispose to atopic dermatitis (AD) galvanized the dermatology research community and shed new light on a skin protein that was first identified in 1981. However, although outstanding work has uncovered several key functions of filaggrin in epidermal homeostasis, a comprehensive understanding of how filaggrin deficiency contributes to AD is still incomplete, including details of the upstream factors that lead to the reduced amounts of filaggrin, regardless of genotype. In this review, we re-evaluate data focusing on the roles of filaggrin in the epidermis, as well as in AD. Filaggrin is important for alignment of keratin intermediate filaments, control of keratinocyte shape, and maintenance of epidermal texture via production of water-retaining molecules. Moreover, filaggrin deficiency leads to cellular abnormalities in keratinocytes and induces subtle epidermal barrier impairment that is sufficient enough to facilitate the ingress of certain exogenous molecules into the epidermis. However, although FLG null mutations regulate skin moisture in non-lesional AD skin, filaggrin deficiency per se does not lead to the neutralization of skin surface pH or to excessive transepidermal water loss in atopic skin. Separating facts from chaff regarding the functions of filaggrin in the epidermis is necessary for the design efficacious therapies to treat dry and atopic skin. Full article
(This article belongs to the Special Issue Filaggrin)
Show Figures

Figure 1

Back to TopTop